Arla Foods Ingredients launching dry-blend MFGM

By Jim Cornall contact

- Last updated on GMT

Lacprodan MFGM-10 was the first MFGM ingredient for the global infant formula market. Pic: Arla Foods Ingredients
Lacprodan MFGM-10 was the first MFGM ingredient for the global infant formula market. Pic: Arla Foods Ingredients

Related tags: Infant formula, Arla, Arla foods ingredients, Milk

Arla Foods Ingredients is launching a dry-blend version of its MFGM (milk fat globule membrane) ingredient.

The company said this will help formula manufacturers reduce energy usage and production costs without compromising on safety or quality.

Lacprodan MFGM-10, which is rich in phospholipids and gangliosides, was the first MFGM ingredient for the global infant formula market.

The new dry-blend option – Lacprodan Premium MFGM-10, uses dry-blending, a process that allows manufacturers to reduce energy usage and production costs. It also provides greater flexibility to produce more recipes from one base powder.

Also, the dry-blending process requires particularly high microbiological compliance throughout the entire batch of the ingredient, which ensures consistent quality and product safety. Arla Foods Ingredients said this also means Lacprodan Premium MFGM-10 is free from Cronobacter sakazakii​, a bacterium that can cause serious infections in infants.

Niels Joakim Karlsen, pediatric sales development manager at Arla Foods Ingredients, said, “MFGM is a key ingredient for the global formula market. By offering Lacprodan MFGM-10 in a dry blend form, we’re combining the clinically proven benefits of this ingredient with opportunities to reduce energy usage and production costs while ensuring high quality and product safety.”

 

Related news

Related products

show more

Actilight® and infant nutrition: new perspectives

Actilight® and infant nutrition: new perspectives

Tereos | 31-Aug-2021 | Technical / White Paper

Addition of prebiotic ingredients to formulas started around 30 years ago and is widely recognized by experts. Actilight® scFOS is safe for use in infant...

Business case: private label iron supplements

Business case: private label iron supplements

PharmaLinea Ltd. | 18-May-2021 | Case Study

A line of clinically supported private label iron supplements by PharmaLinea is selling nearly 500.000 units/year in a market of under 20 million people.

Time to rethink your probiotics for infant use

Time to rethink your probiotics for infant use

Morinaga Milk Industry Co., Ltd. | 17-Sep-2020 | Technical / White Paper

Undoubtedly, probiotics-fortified infant nutrition products have hit the mainstream, and a baby-friendly concept is on the consumer radar. Morinaga's...

Related suppliers

Follow us

Products

View more

Webinars